"Nintedanib in children and adolescents with fibrosing interstitial lung diseases." R. Deterding, L.R. Young, E.M. DeBoer, D. Warburton, S. Cunningham, N. Schwerk, K.R. Flaherty, K.K. Brown, M. Dumistracel, E. Erhardt, J. Bertulis, M. Gahlemann, S. Stowasser and M. Griese for the InPedILD trial investigators. Eur Respir J 2023; 61: 2201512
- PMID: 37230503
- DOI: 10.1183/13993003.51512-2022
"Nintedanib in children and adolescents with fibrosing interstitial lung diseases." R. Deterding, L.R. Young, E.M. DeBoer, D. Warburton, S. Cunningham, N. Schwerk, K.R. Flaherty, K.K. Brown, M. Dumistracel, E. Erhardt, J. Bertulis, M. Gahlemann, S. Stowasser and M. Griese for the InPedILD trial investigators. Eur Respir J 2023; 61: 2201512
Erratum for
-
Nintedanib in children and adolescents with fibrosing interstitial lung diseases.Eur Respir J. 2023 Feb 2;61(2):2201512. doi: 10.1183/13993003.01512-2022. Print 2023 Feb. Eur Respir J. 2023. PMID: 36041751 Free PMC article. Clinical Trial.
Similar articles
-
"Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis." Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek. Eur Respir J 2018; 52: 1800230.Eur Respir J. 2018 Oct 4;52(4):1850230. doi: 10.1183/13993003.50230-2018. Print 2018 Oct. Eur Respir J. 2018. PMID: 30287496 Free PMC article. No abstract available.
-
Nintedanib in children and adolescents with fibrosing interstitial lung diseases.Eur Respir J. 2023 Feb 2;61(2):2201512. doi: 10.1183/13993003.01512-2022. Print 2023 Feb. Eur Respir J. 2023. PMID: 36041751 Free PMC article. Clinical Trial.
-
"Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis." S.M. Kawut, M.J. Krowka, K.A. Forde, N. Al-Naamani, K.L. Krok, M. Patel, C.R. Bartoli, M. Doyle, J. Moutchia, G. Lin, J.K. Oh, C.D. Mottram, P.D. Scanlon and M.B. Fallon for the Pulmonary Vascular Complications of Liver Disease Study Group. Eur Respir J 2022; 60: 2102304.Eur Respir J. 2023 Jul 27;62(1):2152304. doi: 10.1183/13993003.52304-2021. Print 2023 Jul. Eur Respir J. 2023. PMID: 37500111 No abstract available.
-
Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.Mod Rheumatol. 2021 Jan;31(1):13-19. doi: 10.1080/14397595.2020.1826665. Mod Rheumatol. 2021. PMID: 32964766 Review.
-
Functional tissue engineering for ligament healing: potential of antisense gene therapy.Ann Biomed Eng. 2004 Mar;32(3):342-51. doi: 10.1023/b:abme.0000017551.93144.1a. Ann Biomed Eng. 2004. PMID: 15098538 Review.
Publication types
LinkOut - more resources
Full Text Sources